Lung cancer DNA vaccine (Immune Cell Therapy)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLung cancer DNA vaccine (Immune Cell Therapy)
Drug Alias NameIC-1001
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsGene transference
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesImmune Cell Therapy Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmune Cell Therapy Inc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A